2026-10-27 06:19:12 UTC#518942newconfirmednews
PolyPeptide Group AG stock news
PolyPeptide Group AG stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-16 05:08:17 UTC#469959newconfirmednews
Samsung Biologics secures 87.92% stake in PolyPeptide Group, plans squeeze-out and delisting
2026-10-07 07:59:00 UTC#424092updateconfirmednews
UBS cuts PolyPeptide Group AG price target to CHF44.00 from CHF45.00
2026-10-07 07:59:00 UTC#424090newconfirmednews
UBS downgrades Polypeptide Group AG to Neutral from Buy
2026-08-31 09:47:00 UTC#241580duplicateconfirmednews
Summary of M&A activity: Samsung Biologics, ONEOK, and Aon deals reported
reutersimportance 0.30trust 0.80Samsung Biologics Co., Ltd. +0.30PolyPeptide Group AG -0.30ONEOK, Inc. +0.40+2 entities
2026-08-31 07:27:28 UTC#241212duplicateconfirmednews
Samsung Biologics subsidiary Samsung Peptide confirms 2.7 trillion won share purchase in PolyPeptide Group AG
reutersimportance 0.30trust 0.90Samsung Biologics Co., Ltd. +0.40PolyPeptide Group AG -0.30Samsung Peptide +0.40
2026-08-31 05:47:00 UTC#240923duplicateconfirmednews
Samsung Biologics tender offer for PolyPeptide Group remains ongoing
2026-08-31 05:36:16 UTC#240888duplicateconfirmednews
Samsung Biologics confirms September 15 launch for CHF 44.31 per share PolyPeptide takeover bid
reutersimportance 0.40trust 0.90Samsung Biologics Co., Ltd. +0.30PolyPeptide Group AG +0.30Samsung Peptide AG +0.20
2026-08-31 05:12:11 UTC#240781duplicateconfirmednews
Samsung Peptide launches CHF 44.31 per share takeover bid for PolyPeptide Group
reutersimportance 0.50trust 0.90Samsung Peptide +0.50PolyPeptide Group AG +0.50Samsung Biologics +0.30
2026-08-31 05:00:00 UTC#240767duplicateconfirmedpress release
Samsung Biologics subsidiary Samsung Peptide publishes formal tender offer prospectus for PolyPeptide Group AG
pr_newswireimportance 0.50trust 1.00Samsung Biologics Co., Ltd. +0.30PolyPeptide Group AG +0.50Samsung Peptide AG +0.30
2026-08-31 04:58:41 UTC#240745newconfirmednews
Samsung Peptide AG launches CHF 44.31 per share tender offer for PolyPeptide Group AG
2026-08-28 04:35:09 UTC#233114duplicateconfirmednews
Samsung Biologics to raise 3 trillion won in rights offering for PolyPeptide acquisition
2026-08-28 02:21:00 UTC#232806duplicateconfirmednews
Samsung Biologics details 3 trillion won rights issue to fund PolyPeptide Group acquisition
dow_jonesimportance 0.30trust 0.90Samsung Biologics Co., Ltd. +0.30PolyPeptide Group AG +0.40Samsung Group 0+2 entities
2026-08-28 02:06:00 UTC#232769duplicateconfirmednews
Samsung Biologics confirms $2.17B rights issue to fund PolyPeptide Group acquisition
dow_jonesimportance 0.30trust 0.90Samsung Biologics Co., Ltd. +0.30PolyPeptide Group AG +0.40Samsung Group 0
2026-08-28 01:37:06 UTC#232689duplicateconfirmednews
Samsung Biologics to Raise $2.2 Billion via Rights Offering to Fund PolyPeptide Group Acquisition
2026-08-28 00:17:00 UTC#232428duplicateconfirmednews
Samsung Biologics to acquire PolyPeptide Group for $1.96 billion, plans 3 trillion won rights issue
dow_jonesimportance 0.40trust 0.80Samsung Biologics Co., Ltd. +0.40PolyPeptide Group AG +0.40Samsung Group 0+2 entities
2026-08-27 23:44:00 UTC#232317updateconfirmednews
Samsung Biologics to acquire PolyPeptide Group for KRW 2.706 trillion
2026-08-27 22:58:00 UTC#232129updateconfirmedpress release
Samsung Biologics to raise KRW 3 trillion via rights offering to fund PolyPeptide Group acquisition and Bio Campus II expansion
2026-08-18 05:33:00 UTC#187895updateconfirmednews
Berenberg Raises PolyPeptide Group AG Price Target to CHF44.00 From CHF38.00
2026-08-18 05:33:00 UTC#187894newconfirmednews